Unity's Q4 revenue dropped 25% to $457.1M but beat estimates, prompting analyst reratings and cautious optimism on future growth. Analysts see potential in Unity 6 adoption and ad platform upgrades, ...
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UBX) (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile
Părere